scispace - formally typeset
S

Silvia Santopolo

Researcher at Sapienza University of Rome

Publications -  8
Citations -  104

Silvia Santopolo is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 3, co-authored 3 publications receiving 68 citations.

Papers
More filters
Journal ArticleDOI

DOF AFFECTING GERMINATION 2 is a positive regulator of light-mediated seed germination and is repressed by DOF AFFECTING GERMINATION 1

TL;DR: The present data prove that DAG2 is a positive regulator of the light-mediated seed germination process, and particularly reveal that this protein plays its main role downstream of PIL5 and DAG1 in the phytochrome B (phyB)-mediated pathway.
Journal ArticleDOI

The DOF Protein DAG1 and the DELLA Protein GAI Cooperate in Negatively Regulating the AtGA3ox1 Gene

TL;DR: This work has demonstrated that DAG1 specifi­ cally represses AtGA3ox1 expression, and confirmed that GAI plays a role in the regulation of GA metabolic genes, and in particular of AtGA2ox1, and performed a quantitative RT–PCR analysis on gai-t6 mutant seeds.
Journal ArticleDOI

Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence

TL;DR: In this article , the authors demonstrate that nitazoxanide, an antiprotozoal agent with recognized broad-spectrum antiviral activity, interferes with SARS-CoV-2 spike maturation, hampering its terminal glycosylation at an endoglycosidase H-sensitive stage.
Posted ContentDOI

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein

TL;DR: The results indicate that nitazoxanide, due to its broad-spectrum anti-coronavirus activity, may represent a readily available useful tool in the treatment of seasonal coronavirus infections.